Table 1.
Patient Baseline Demographics
| Magnesium (n = 61) | Metoclopramide (n = 44) | Prochlorperazine (n = 52) | p Value | |
|---|---|---|---|---|
| Age, median (IQR) | 34 (27–48) | 37.5 (29.5–48) | 37.5 (27–47.5) | 0.67 |
| BMI, median (IQR) | 31.2 (25.5–35.9) | 30.1 (26.2–34.4) | 33.4 (26.5–36.2) | 0.52 |
| Female sex, No. (%) | 44 (72) | 33 (75) | 46 (88) | 0.09 |
| Race, No.(%) | ||||
| White | 30 (49) | 23 (52) | 14 (27) | 0.07 |
| Black | 25 (41) | 16 (36) | 28 (54) | 0.19 |
| Hispanic | 6 (10) | 5 (11) | 9 (17) | 0.47 |
| Comorbidities, No. (%) | ||||
| Migraine/Headache | 17 (28) | 13 (29.5) | 19 (36.5) | 0.59 |
| Hypertension | 15 (25) | 10 (23) | 15 (29) | 0.78 |
| Diabetes | 8 (13) | 7 (16) | 5 (10) | 0.65 |
| Depression/Anxiety | 7 (11.5) | 5 (11) | 3 (6) | 0.63 |
| Asthma | 4 (6.5) | 6 (14) | 7 (13) | 0.39 |
| Gastrointestinal disorders | 5 (8) | 5 (11) | 4 (8) | 0.79 |
| Aneurysm/ICH | 3 (5) | 3 (7) | 3 (6) | 0.92 |
| Arthritis/MSK pain | 4 (6.5) | 3 (7) | 3 (6) | 0.98 |
| Presence of aura, No. (%) | 18 (29.5) | 14 (32) | 20 (38.5) | 0.52 |
Abbreviations: BMI, body mass index; ICH, intercranial hemorrhage; IQR, interquartile range; MSK, musculoskeletal.